BUSINESS COMBINATION AGREEMENT BY AND AMONG Priveterra Acquisition Corp., PRIVETERRA MERGER SUB, INC. AND AEON Biopharma, INC. DATED AS OF DECEMBER 12, 2022Registration Rights Agreement • December 13th, 2022 • Priveterra Acquisition Corp. • Blank checks • Delaware
This BUSINESS COMBINATION AGREEMENT (this “Agreement”), dated as of December 12, 2022, is made by and among Priveterra Acquisition Corp., a Delaware corporation (“Priveterra”), Priveterra Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and AEON Biopharma, Inc., a Delaware corporation (the “Company”). Priveterra, Merger Sub and the Company shall be referred to herein from time to time collectively as the “Parties” (and each a “Party”). Capitalized terms used herein have the meanings set forth in Section 1.1 and Section 1.2.
